Cefaloglycin
From Wikipedia, the free encyclopedia
|
Cefaloglycin
|
|
| Systematic (IUPAC) name | |
| 4-(acetyloxymethyl)-8- (2-amino-2-phenyl-acetyl) amino-7-oxo-2-thia-6-azabicyclo [4.2. 0] oct-4-ene-5-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C18H19N3O6S |
| Mol. mass | 405.426 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Cefaloglycin INN (also spelled cephaloglycin) is a first generation cephalosporin antibiotic.
[edit] External links
- Tune B, Hsu C (1990). "The renal mitochondrial toxicity of beta-lactam antibiotics: in vitro effects of cephaloglycin and imipenem.". J Am Soc Nephrol 1 (5): 815–21. PMID 2133431.
- Tune B, Fravert D, Hsu C (1989). "Oxidative and mitochondrial toxic effects of cephalosporin antibiotics in the kidney. A comparative study of cephaloridine and cephaloglycin.". Biochem Pharmacol 38 (5): 795–802. doi:. PMID 2930580.
|
||||||||||||||||||||

